NCT03797885View on ClinicalTrials.gov

A Study of People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in Portugal

CompletedOBSERVATIONAL
Enrollment

730

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

October 15, 2019

Study Completion Date

October 15, 2019

Conditions
Diabetes Mellitus, Type 2
Interventions
OTHER

No treatment given

No treatment is administered to the participants for this study

Trial Locations (14)

2805-267

Novo Nordisk Investigational Site, Almada

2500-176

Novo Nordisk Investigational Site, Caldas da Rainha

2410-197

Novo Nordisk Investigational Site, Leiria

1349-019

Novo Nordisk Investigational Site, Lisbon

1500-650

Novo Nordisk Investigational Site, Lisbon

1600-777

Novo Nordisk Investigational Site, Lisbon

4464-513

Novo Nordisk Investigational Site, Matosinhos Municipality

8500-338

Novo Nordisk Investigational Site, Portimão

4099-001

Novo Nordisk Investigational Site, Porto

4200-319

Novo Nordisk Investigational Site, Porto

4901-858

Novo Nordisk Investigational Site, Viana do Castelo

4434-502

Novo Nordisk Investigational Site, Vila Nova de Gaia

5000-508

Novo Nordisk Investigational Site, Vila Real

3504-509

Novo Nordisk Investigational Site, Viseu

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY